You are writing regarding

S.1082 Medical Device User Fee Amendments of 2007, 110th Congress

Contact Congress

1. Choose Your Position
2. Write Your Letter
3. Share Your Communication

OpenCongress Message Builder

OpenCongress Message Builder

Use the tools in this column to help craft your letter. Anytime your mouse highlights a section, click on it to add prepared text. You can edit any part of the message at left, and if you like, add your own stories and text to personalize your letter.

Official Bill Info

  • Latest Action: May 10, 2007 Held at the desk.

    Clicking this will add the following text:

    I know the most recent action for this bill is as follows: "Held at the desk." on May 10, 2007
  • Committee Assignment: Senate Health, Education, Labor, and Pensions

    Clicking this will add the following text:

    This bill has been assigned to the Senate Health, Education, Labor, and Pensions committee.
  • This bill's most-recent vote occurred on May 09, 2007, with a roll call of 93 ayes, 1 nays, and 6 not voting.

    Clicking this will add the following text:

    This bill's most-recent vote occurred on May 09, 2007, with a roll call of 93 ayes, 1 nays, and 6 not voting.

Bill Statistics on OpenCongress

  • 100% of users oppose S.1082

    Clicking this will add the following text:

    100% of users on OpenCongress.org, a free, non-partisan resource, oppose S.1082.
  • S.1082 has been viewed 23,542 times

    Clicking this will add the following text:

    S.1082 has been viewed 23,542 times on OpenCongress.org, a free, non-partisan resource.

    • Contribution Data

    Enter your street address above, and relevant campaign contribution data for your elected officials will appear here in seconds for you to use in your letter.

    Most-commented sections of the bill text

    Highest Rated User Comments

    • On December 08, 2008, by Anonymous - With the passing of S 1082, the Food and Drug Company effectively becomes a drug company that is guaranteed $350 million in fees from Big Pharma and none of their research has to be bogged down with any actual science. Think we have health problems now, just wait.

      Clicking this will add the following text:

      As noted by Anonymous, a user on OpenCongress.org, on December 08, 2008, "With the passing of S 1082, the Food and Drug Company effectively becomes a drug company that is guaranteed $350 million in fees from Big Pharma and none of their research has to be bogged down with any actual science. Think we have health problems now, just wait."
    • On January 25, 2008, by Anonymous - I fail to see how allowing the sale of baby turtles, shown to cause thousands of cases of salmonellosis a year (Cohen ML, Potter M, Pollard R, Feldman RA: Turtle-associated salmonellosis in the United States: effect of public health action,1970 to 1976. JAMA 1980;243: 1247-79) is a pharmaceutical access issue. Unless you need access to the drugs to cure the disease they will cause.

      Clicking this will add the following text:

      As noted by Anonymous, a user on OpenCongress.org, on January 25, 2008, "I fail to see how allowing the sale of baby turtles, shown to cause thousands of cases of salmonellosis a year (Cohen ML, Potter M, Pollard R, Feldman RA: Turtle-associated salmonellosis in the United States: effect of public health action,1970 to 1976. JAMA 1980;243: 1247-79) is a pharmaceutical access issue. Unless you need access to the drugs to cure the disease they will cause. "

    Highly Rated Blog Articles

    • The Week Ahead in Congress - Blog - OpenCongress - May 31, 2011 by Donny Shaw - The House kicks things off this week with a vote on raising the debt ceiling by more than $2 trillion. But don't worry, it won't pass. The Republicans have put the bill on the calendar in order to prove a point. ... 4) S. 1082 – Small Business Te

      Clicking this will add the following text:

      As noted by Donny Shaw on May 31, 2011, "The House kicks things off this week with a vote on raising the debt ceiling by more than $2 trillion. But don't worry, it won't pass. The Republicans have put the bill on the calendar in order to prove a point. ... 4) S. 1082 – Small Business Te" (http://www.opencongress.org/articles/view/2303-The-Week-Ahead-in-Congress)
    • S.1082: Small Business Additional Temporary ... - OpenCongress - May 25, 2011 by opencongress.org - S.1082 - Small Business Additional Temporary Extension Act of 2011. A bill to provide for an additional temporary extension of programs under the Small Business Act and the Small Business Investment Act of 1958, ... -

      Clicking this will add the following text:

      As noted by opencongress.org on May 25, 2011, "S.1082 - Small Business Additional Temporary Extension Act of 2011. A bill to provide for an additional temporary extension of programs under the Small Business Act and the Small Business Investment Act of 1958, ... - " (http://www.opencongress.org/bill/112-s1082/show)
    • S.627: Faster FOIA Act of 2011 - U.S. Congress - OpenCongress - March 16, 2011 by opencongress.org - S.1082, Small Business extension -Passed H.R.754, Intelligence Authorization Act for Fiscal Year 2011 (voice vote). -Passed S.627, Faster FIOA Act w/ committee-reported amendments. -Discharged and adopted S.Con.Res.4, A concurrent resolution ... •Cost Es

      Clicking this will add the following text:

      As noted by opencongress.org on March 16, 2011, "S.1082, Small Business extension -Passed H.R.754, Intelligence Authorization Act for Fiscal Year 2011 (voice vote). -Passed S.627, Faster FIOA Act w/ committee-reported amendments. -Discharged and adopted S.Con.Res.4, A concurrent resolution ... •Cost Es" (http://www.opencongress.org/bill/112-s627/show)

    Highly Rated News Articles

    • Follow-On Biologics Will Not Make PDUFA, Enzi Spokesman Says - September 17, 2007 by FDA news (subscription) - The Senate version of FDARA, S. 1082, contains a placeholder for follow-on biologics legislation, while HR 2900, the House version, does not. ...

      Clicking this will add the following text:

      As noted by FDA news (subscription) on September 17, 2007, "The Senate version of FDARA, S. 1082, contains a placeholder for follow-on biologics legislation, while HR 2900, the House version, does not. ..." (http://fdanews.com/newsletter/article?issueId=10742&articleId=98656)
    • Will Follow-On Biologics Bill Become Law? - September 16, 2007 by Patent Baristas, OH - The two versions of the bills, S. 1082 and HR 2900, are currently pending before a conference committee. The Senate version of the bill contains a ...

      Clicking this will add the following text:

      As noted by Patent Baristas, OH on September 16, 2007, "The two versions of the bills, S. 1082 and HR 2900, are currently pending before a conference committee. The Senate version of the bill contains a ..." (http://www.patentbaristas.com/archives/2007/09/17/will-follow-on-biologics-bill-become-law/)
    • Citizen Petition Reforms Under Revised PDUFA to Have Limited Impact - September 13, 2007 by FDA news (subscription) - Two versions of the legislation, S. 1082 and HR 2900, are currently pending before a conference committee. Conferees have not been appointed to reconcile ...

      Clicking this will add the following text:

      As noted by FDA news (subscription) on September 13, 2007, "Two versions of the legislation, S. 1082 and HR 2900, are currently pending before a conference committee. Conferees have not been appointed to reconcile ..." (http://fdanews.com/newsletter/article?issueId=10731&articleId=98548)
    Enter your street address at right to find your members of Congress.
    A Letter to Congress from a constituent via OpenCongress.org

    After sending, this letter will be viewable to:

    Characters Remaining:  
    • Click "Send Message" above to complete delivery of this email. (If you don't already have a free "My OpenCongress" account, we'll make one for you now.)
    • Congressional offices require all address information in the form above be completed in order to deliver your email.
    • OpenCongress does not share your address information with any outside parties for any reason.

    OpenCongress is the only not-for-profit website that enables you to write all three of your members of Congress at once.

    OpenCongress is the only website that gives this information back to the public commons, enabling you to find other constituents near you who are tracking the same bills and issues.

    Supporting and Opposing Industries information on this page comes from MAPLight.org, a non-partisan & non-profit organization.

    Campaign contribution data on this page comes from the Center for Responsive Politics, a non-partisan & non-profit organization.

    Other information on this page is uniquely aggregated by OpenCongress, a free & open-source project of the Participatory Politics Foundation, a non-partisan & non-profit organization.

    OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.